 | • レポートコード：MRC309Z7893 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の静脈内全身麻酔薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の静脈内全身麻酔薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 静脈内全身麻酔薬の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 静脈内全身麻酔薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・鎮静剤、鎮痛剤、筋弛緩剤 用途別セグメント ・病院、診療所 主要な市場プレーヤー ・AstraZeneca、Fresenius-Kabi、AbbVie、Baxter Healthcare、B. Braun Melsungen、Liaoning Haisco、Pfizer、Teva Pharmaceutical Industries、Fresenius Kabi AG、SGPharma、Jiangsu Nhua Pharmaceutical Co., Ltd.、Xi'an Libang Pharmaceutical Co., Ltd.、Baxter international、Sichuan Guorui Pharmaceutical Co., Ltd.、Hikma 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、静脈内全身麻酔薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な静脈内全身麻酔薬メーカーの企業概要、2019年～2022年までの静脈内全身麻酔薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な静脈内全身麻酔薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別静脈内全身麻酔薬の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの静脈内全身麻酔薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での静脈内全身麻酔薬市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および静脈内全身麻酔薬の産業チェーンを掲載しています。 ・第14、15章では、静脈内全身麻酔薬の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 静脈内全身麻酔薬の概要 - 種類別分析（2018年vs2022年vs2029年）：鎮静剤、鎮痛剤、筋弛緩剤 - 用途別分析（2018年vs2022年vs2029年）：病院、診療所 - 世界の静脈内全身麻酔薬市場規模・予測 - 世界の静脈内全身麻酔薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - AstraZeneca、Fresenius-Kabi、AbbVie、Baxter Healthcare、B. Braun Melsungen、Liaoning Haisco、Pfizer、Teva Pharmaceutical Industries、Fresenius Kabi AG、SGPharma、Jiangsu Nhua Pharmaceutical Co., Ltd.、Xi'an Libang Pharmaceutical Co., Ltd.、Baxter international、Sichuan Guorui Pharmaceutical Co., Ltd.、Hikma ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：鎮静剤、鎮痛剤、筋弛緩剤 ・用途別分析2018年-2029年：病院、診療所 ・静脈内全身麻酔薬の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・静脈内全身麻酔薬のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・静脈内全身麻酔薬のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・静脈内全身麻酔薬の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・静脈内全身麻酔薬の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Intravenous General Anesthetics market size was valued at USD 5721 million in 2022 and is forecast to a readjusted size of USD 7289.4 million by 2029 with a CAGR of 3.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Intravenous anesthesia is administered through a vein to provide general anesthesia.
This report is a detailed and comprehensive analysis for global Intravenous General Anesthetics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Intravenous General Anesthetics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intravenous General Anesthetics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intravenous General Anesthetics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intravenous General Anesthetics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intravenous General Anesthetics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intravenous General Anesthetics market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare and B. Braun Melsungen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Intravenous General Anesthetics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sedative
Analgesics
Muscle Relaxants
Market segment by Application
Hospital
Clinic
Major players covered
AstraZeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B. Braun Melsungen
Liaoning Haisco
Pfizer
Teva Pharmaceutical Industries
Fresenius Kabi AG
SGPharma
Jiangsu Nhua Pharmaceutical Co., Ltd.
Xi’an Libang Pharmaceutical Co., Ltd.
Baxter international
Sichuan Guorui Pharmaceutical Co., Ltd.
Hikma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous General Anesthetics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intravenous General Anesthetics, with price, sales, revenue and global market share of Intravenous General Anesthetics from 2018 to 2023.
Chapter 3, the Intravenous General Anesthetics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous General Anesthetics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Intravenous General Anesthetics market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intravenous General Anesthetics.
Chapter 14 and 15, to describe Intravenous General Anesthetics sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Intravenous General Anesthetics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Intravenous General Anesthetics Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Sedative
1.3.3 Analgesics
1.3.4 Muscle Relaxants
1.4 Market Analysis by Application
1.4.1 Overview: Global Intravenous General Anesthetics Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Intravenous General Anesthetics Market Size & Forecast
1.5.1 Global Intravenous General Anesthetics Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Intravenous General Anesthetics Sales Quantity (2018-2029)
1.5.3 Global Intravenous General Anesthetics Average Price (2018-2029)
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Intravenous General Anesthetics Product and Services
2.1.4 AstraZeneca Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AstraZeneca Recent Developments/Updates
2.2 Fresenius-Kabi
2.2.1 Fresenius-Kabi Details
2.2.2 Fresenius-Kabi Major Business
2.2.3 Fresenius-Kabi Intravenous General Anesthetics Product and Services
2.2.4 Fresenius-Kabi Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Fresenius-Kabi Recent Developments/Updates
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Intravenous General Anesthetics Product and Services
2.3.4 AbbVie Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AbbVie Recent Developments/Updates
2.4 Baxter Healthcare
2.4.1 Baxter Healthcare Details
2.4.2 Baxter Healthcare Major Business
2.4.3 Baxter Healthcare Intravenous General Anesthetics Product and Services
2.4.4 Baxter Healthcare Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Baxter Healthcare Recent Developments/Updates
2.5 B. Braun Melsungen
2.5.1 B. Braun Melsungen Details
2.5.2 B. Braun Melsungen Major Business
2.5.3 B. Braun Melsungen Intravenous General Anesthetics Product and Services
2.5.4 B. Braun Melsungen Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 B. Braun Melsungen Recent Developments/Updates
2.6 Liaoning Haisco
2.6.1 Liaoning Haisco Details
2.6.2 Liaoning Haisco Major Business
2.6.3 Liaoning Haisco Intravenous General Anesthetics Product and Services
2.6.4 Liaoning Haisco Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Liaoning Haisco Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Intravenous General Anesthetics Product and Services
2.7.4 Pfizer Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments/Updates
2.8 Teva Pharmaceutical Industries
2.8.1 Teva Pharmaceutical Industries Details
2.8.2 Teva Pharmaceutical Industries Major Business
2.8.3 Teva Pharmaceutical Industries Intravenous General Anesthetics Product and Services
2.8.4 Teva Pharmaceutical Industries Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Teva Pharmaceutical Industries Recent Developments/Updates
2.9 Fresenius Kabi AG
2.9.1 Fresenius Kabi AG Details
2.9.2 Fresenius Kabi AG Major Business
2.9.3 Fresenius Kabi AG Intravenous General Anesthetics Product and Services
2.9.4 Fresenius Kabi AG Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Fresenius Kabi AG Recent Developments/Updates
2.10 SGPharma
2.10.1 SGPharma Details
2.10.2 SGPharma Major Business
2.10.3 SGPharma Intravenous General Anesthetics Product and Services
2.10.4 SGPharma Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 SGPharma Recent Developments/Updates
2.11 Jiangsu Nhua Pharmaceutical Co., Ltd.
2.11.1 Jiangsu Nhua Pharmaceutical Co., Ltd. Details
2.11.2 Jiangsu Nhua Pharmaceutical Co., Ltd. Major Business
2.11.3 Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product and Services
2.11.4 Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Jiangsu Nhua Pharmaceutical Co., Ltd. Recent Developments/Updates
2.12 Xi’an Libang Pharmaceutical Co., Ltd.
2.12.1 Xi’an Libang Pharmaceutical Co., Ltd. Details
2.12.2 Xi’an Libang Pharmaceutical Co., Ltd. Major Business
2.12.3 Xi’an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product and Services
2.12.4 Xi’an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Xi’an Libang Pharmaceutical Co., Ltd. Recent Developments/Updates
2.13 Baxter international
2.13.1 Baxter international Details
2.13.2 Baxter international Major Business
2.13.3 Baxter international Intravenous General Anesthetics Product and Services
2.13.4 Baxter international Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Baxter international Recent Developments/Updates
2.14 Sichuan Guorui Pharmaceutical Co., Ltd.
2.14.1 Sichuan Guorui Pharmaceutical Co., Ltd. Details
2.14.2 Sichuan Guorui Pharmaceutical Co., Ltd. Major Business
2.14.3 Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product and Services
2.14.4 Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sichuan Guorui Pharmaceutical Co., Ltd. Recent Developments/Updates
2.15 Hikma
2.15.1 Hikma Details
2.15.2 Hikma Major Business
2.15.3 Hikma Intravenous General Anesthetics Product and Services
2.15.4 Hikma Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Hikma Recent Developments/Updates
3 Competitive Environment: Intravenous General Anesthetics by Manufacturer
3.1 Global Intravenous General Anesthetics Sales Quantity by Manufacturer (2018-2023)
3.2 Global Intravenous General Anesthetics Revenue by Manufacturer (2018-2023)
3.3 Global Intravenous General Anesthetics Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Intravenous General Anesthetics by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Intravenous General Anesthetics Manufacturer Market Share in 2022
3.4.2 Top 6 Intravenous General Anesthetics Manufacturer Market Share in 2022
3.5 Intravenous General Anesthetics Market: Overall Company Footprint Analysis
3.5.1 Intravenous General Anesthetics Market: Region Footprint
3.5.2 Intravenous General Anesthetics Market: Company Product Type Footprint
3.5.3 Intravenous General Anesthetics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Intravenous General Anesthetics Market Size by Region
4.1.1 Global Intravenous General Anesthetics Sales Quantity by Region (2018-2029)
4.1.2 Global Intravenous General Anesthetics Consumption Value by Region (2018-2029)
4.1.3 Global Intravenous General Anesthetics Average Price by Region (2018-2029)
4.2 North America Intravenous General Anesthetics Consumption Value (2018-2029)
4.3 Europe Intravenous General Anesthetics Consumption Value (2018-2029)
4.4 Asia-Pacific Intravenous General Anesthetics Consumption Value (2018-2029)
4.5 South America Intravenous General Anesthetics Consumption Value (2018-2029)
4.6 Middle East and Africa Intravenous General Anesthetics Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
5.2 Global Intravenous General Anesthetics Consumption Value by Type (2018-2029)
5.3 Global Intravenous General Anesthetics Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
6.2 Global Intravenous General Anesthetics Consumption Value by Application (2018-2029)
6.3 Global Intravenous General Anesthetics Average Price by Application (2018-2029)
7 North America
7.1 North America Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
7.2 North America Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
7.3 North America Intravenous General Anesthetics Market Size by Country
7.3.1 North America Intravenous General Anesthetics Sales Quantity by Country (2018-2029)
7.3.2 North America Intravenous General Anesthetics Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
8.2 Europe Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
8.3 Europe Intravenous General Anesthetics Market Size by Country
8.3.1 Europe Intravenous General Anesthetics Sales Quantity by Country (2018-2029)
8.3.2 Europe Intravenous General Anesthetics Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Intravenous General Anesthetics Market Size by Region
9.3.1 Asia-Pacific Intravenous General Anesthetics Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Intravenous General Anesthetics Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
10.2 South America Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
10.3 South America Intravenous General Anesthetics Market Size by Country
10.3.1 South America Intravenous General Anesthetics Sales Quantity by Country (2018-2029)
10.3.2 South America Intravenous General Anesthetics Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Intravenous General Anesthetics Market Size by Country
11.3.1 Middle East & Africa Intravenous General Anesthetics Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Intravenous General Anesthetics Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Intravenous General Anesthetics Market Drivers
12.2 Intravenous General Anesthetics Market Restraints
12.3 Intravenous General Anesthetics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Intravenous General Anesthetics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intravenous General Anesthetics
13.3 Intravenous General Anesthetics Production Process
13.4 Intravenous General Anesthetics Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intravenous General Anesthetics Typical Distributors
14.3 Intravenous General Anesthetics Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer